Antibe Therapeutics Competitors and Similar CompaniesClear all

Antibe Therapeutics's competitors and similar companies include GBT (Global Blood Therapeutics), Treeway, Capo Therapeutics and Certa Therapeutics.

	Antibe Therapeutics Antibe Therapeutics is a biotechnology company that specializes in the treatment of pain and inflammation.	GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.	Treeway Treeway is a clinical-stage biotechnology company.	Capo Therapeutics Capo Therapeutics is a company that provides vaccine therapies for debilitating diseases of the brain.	Certa Therapeutics Certa Therapeutics is a biotechnology company developing therapies for the treatment of fibrotic diseases.
Founding Date	Founding Date 2009	Founding Date 2012	Founding Date 2012	Founding Date N/A	Founding Date N/A
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Toronto, CA HQ	Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB	Locations Tilburg, NL HQ	Locations HQ	Locations HQ
Employees	Employees 44	Employees 352106% increase	Employees 12	Employees N/A	Employees 12
Valuation ($)	Valuation ($) 121.9 m	Valuation ($) 4.4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $7m (FY, 2023)	Revenue (est.) $194.7m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $3.9m (FY, 2023)	Cost of goods $3.3m (FY, 2021)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Net income	Net income ($19.5m) (FY, 2023)	Net income ($303.1m) (FY, 2021)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 6.2m	Total funding raised $ 88.7m	Total funding raised $ 55.8k	Total funding raised N/A	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

GBT (Global Blood Therapeutics)

South San Francisco, US

Employees

352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company

Treeway

Tilburg, NL

Employees

Treeway is a clinical-stage biotechnology company.

View company

Capo Therapeutics

Capo Therapeutics is a company that provides vaccine therapies for debilitating diseases of the brain.

View company

Certa Therapeutics

Employees

Certa Therapeutics is a biotechnology company developing therapies for the treatment of fibrotic diseases.